Prospective Study of Sinonasal and Skull-base Tumours Management
NCT05607888 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 120
Last updated 2026-04-29
Summary
This observational prospective clinical study aims to describe the epidemiology, management and outcome of patients with sinonasal and skull-base pathology (tumours and diseases with malignant clinical characteristics) in a tertiary otorhinolaryngology referral centre. The main questions it aims to answer are:
* what is the caseload of patients with the included pathology in our centre
* what are the results of management of these cases
* what are the epidemiological characteristics of included patients
* what is the quality of life of included patients.
Conditions
- Nasal Neoplasm
- Nasal Neoplasm Benign
- Skull Base Neoplasms
- Skull Base Osteomyelitis
- Sinonasal Disorder
- Sinus Disease
Sponsors & Collaborators
-
University of Ljubljana, Faculty of Medicine
collaborator OTHER -
University Medical Centre Ljubljana
lead OTHER
Principal Investigators
-
Domen Vozel, MD, PhD · University Medical Centre Ljubljana
-
Jure Urbančič, MD · University Medical Centre Ljubljana
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-01-01
- Primary Completion
- 2027-01-01
- Completion
- 2027-12-31
Countries
- Slovenia
Study Locations
More Related Trials
-
Stereotactic Radiotherapy for Sinonasal Malignancy
NCT06617910 ·Status: ACTIVE_NOT_RECRUITING
-
A Clinical Trial of Endoscopic Surgery Followed by Chemotherapy and Proton Radiation for the Treatment of Tumors in the Sinus and Nasal Passages
NCT03274414 ·Status: COMPLETED ·Phase: PHASE2
-
Head and Neck Cancer Treatment Patterns and Outcomes Research Study in France, Germany, and Canada
NCT02705833 ·Status: COMPLETED
-
Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and Neck
NCT04664582 ·Status: UNKNOWN ·Phase: NA
-
Induction Treatment in SCC of the Head and Neck Region - Concomitant Chemotherapy and Low-dose Radiotherapy
NCT05992610 ·Status: RECRUITING ·Phase: NA
-
Phase 2 Pragmatic Trial of Sentinel Lymph Node Biopsy (SLNB) in Patients With Clinically Node-Negative (cN0), High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) of the Head and Neck
NCT06990737 ·Status: RECRUITING ·Phase: PHASE2
-
Induction Chemotherapy and Tazemetostat for Locally Advanced SMARCB1-deficient Sinonasal Carcinoma
NCT05151588 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study of Treatment Patterns and Clinical Outcomes in First Line Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (1L R/M SCCHN) Participants in Europe
NCT05123950 ·Status: COMPLETED
-
Head and Neck Cancer in Children: A Retrospective Study
NCT02557048 ·Status: UNKNOWN
-
A Bidirectional Observational Clinical Study of NAIC in the Treatment of Tumor Regression Patterns in LA-OSCC and LA-OPSCC
NCT07133958 ·Status: RECRUITING
-
The Princess Alexandra Hospital and the QIMR Berghofer Medical Research Institute Head and Neck Cancer Study
NCT02126189 ·Status: UNKNOWN
-
Observational Study of Nivolumab in Participants in Germany With Squamous Cell Carcinoma of the Head and Neck (SCCHN) Progressing on or After Platinum-Based Therapy
NCT03114163 ·Status: COMPLETED
-
Neoadjuvant Chemotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck (SCCHN)
NCT01312350 ·Status: COMPLETED ·Phase: PHASE2
-
Magnetic Localization of Sentinel Nodes in Squamous Cell Oral Carcinoma.
NCT06261983 ·Status: RECRUITING
-
Head and Neck Carcinoma Clinical Research Platform for Molecular and Blood-based Biomarkers, Treatment and Outcome
NCT06380686 ·Status: RECRUITING
-
Efficacy Study of Pembrolizumab in Relapsed, Locally Recurrent Squamous Cell Cancer of the Head and Neck
NCT02769520 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Evaluation of Sentinel Lymph Nodes in Head and Neck Squamous Cell Carcinoma
NCT00911326 ·Status: TERMINATED ·Phase: PHASE3
-
Induction Chemotherapy Followed by Chemoradiation With Cetuximab in Head and Neck Cancer
NCT00868491 ·Status: COMPLETED ·Phase: PHASE2
-
Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors
NCT06176989 ·Status: RECRUITING ·Phase: PHASE2
-
Study to Evaluate Immunological Response to PD-1 Inhibition in Squamous Cell Carcinoma of the Head and Neck (SCCHN)
NCT03129061 ·Status: COMPLETED ·Phase: PHASE1
-
Chemoradiotherapy Followed by Surgery for Advanced Paranasal Sinus Cancer
NCT00347256 ·Status: WITHDRAWN ·Phase: NA
-
Clinicopathological Profile of Head and Neck Cancers in Army Hospital of Nepal
NCT06152055 ·Status: COMPLETED
-
Cisplatin Chemoradiation With or Without Cetuximab for Locoregionally Advanced Squamous Cell Carcinomas (SCC) of the Head and Neck
NCT01301248 ·Status: UNKNOWN ·Phase: PHASE2
-
Predicting Immunotherapy Efficacy in Head and Neck Squamous Cell Cancer
NCT05296135 ·Status: WITHDRAWN
-
Multiparametric Imaging-based Intraoperative Navigation for Guidance of Surgical Resection and Postoperative Radiotherapy in Patients With Head-and-neck Tumors
NCT05671458 ·Status: RECRUITING ·Phase: NA